Aandeel CLINICAL LASERTHERMIA SYSTEMS AB
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Clinical Laserthermia Systems AB Nasdaq Stockholm

Aandelen

slotkoers Nasdaq Stockholm
Andere beurzen
- SEK - Intraday-grafiek van Clinical Laserthermia Systems AB
14/05 Clinical Laserthermia Systems AB sluit een exclusieve distributieovereenkomst met MTEC Company CI
30/04 Clinical Laserthermia krijgt goedkeuring van de Amerikaanse FDA voor het Prism botverankeringsaccessoire van ClearPoint MT

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
BioStock: CLS launches in France
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
BioStock: CLS makes progress in prostate cancer in Europe and the US
Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
CLS receives second order from the National Institutes of Health Clinical Center in the US
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
CLS signs agreement with ROSE Urology for treatment of prostate cancer patients with TRANBERG Thermal Therapy System
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
Clinical Laserthermia Systems Names Interim CFO
CLS appoints Håkan Rosqvist as interim CFO
Clinical Laserthermia Systems AB Announces CFO Changes
Notice of Extraordinary General Meeting at Clinical Laserthermia Systems AB
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CLS B
  4. Koers
  5. Nieuws Clinical Laserthermia Systems AB
  6. Andere talen